Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02559362 · ClinicalTrials.gov registry record
Study on Breast Cancer Patient Perspectives of Exercise
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 26
- Enrollment target
NCT02559362: Completed study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT02559362 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02559362 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The goal of the study is to establish the feasibility/willingness of breast cancer patients to delay surgery to do an exercise program, or be randomized to an exercise training program following treatment, and to see if that willingness correlates with prior physical activity history.
Interventions
- BEHAVIORAL Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-06-03 |
What the finished NCT02559362 record still lists
NCT02559362 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT02559362 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02559362 about?
NCT02559362 is a clinical study titled "Study on Breast Cancer Patient Perspectives of Exercise". The goal of the study is to establish the feasibility/willingness of breast cancer patients to delay surgery to do an exercise program, or be randomized to an exercise training program following treatment, and to see if that willingness correlates with prior physical activity history.
What is the current status of trial NCT02559362?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2015-04. Estimated completion is 2016-06-03.
What interventions are being tested in trial NCT02559362?
The interventions under investigation include: Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT02559362?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia